Gabriela M. Orgeron

Implantable Cardioverter‐Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications

Gabriela M. Orgeron, Cynthia A. James, Anneline Te Riele et al. · Journal of the American Heart Association · 2017 · 90 citations · Full text

Medicine, Cardiology, Cardiothoracic Surgery +10

Impact of Exercise Restriction on Arrhythmic Risk Among Patients With Arrhythmogenic Right Ventricular Cardiomyopathy

Weijia Wang, Gabriela M. Orgeron, Crystal Tichnell et al. · Journal of the American Heart Association · 2018 · 87 citations · Full text

Medicine, Cardiology, Clinical Cardiology +14

Subcutaneous Implantable Cardioverter‐Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Transatlantic Experience

Gabriela M. Orgeron, Aditya Bhonsale, Federico Migliore et al. · Journal of the American Heart Association · 2018 · 30 citations · Full text

Medicine, Cardiology, Surgery +14

Performance of the 2015 International Task Force Consensus Statement Risk Stratification Algorithm for Implantable Cardioverter-Defibrillator Placement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

Gabriela M. Orgeron, Anneline Te Riele, Crystal Tichnell et al. · Circulation Arrhythmia and Electrophysiology · 2018 · 22 citations · Full text

Medicine, Cardiology, Cardiothoracic Surgery +9

Comparing clinical performance of current implantable cardioverter-defibrillator implantation recommendations in arrhythmogenic right ventricular cardiomyopathy

L Bosman, Claire L Nielsen Gerlach, Julia Cadrin‐Tourigny et al. · EP Europace · 2021 · 15 citations · Full text

Medicine, Cardiology, Cardiothoracic Surgery +8